Laboratory Corporation of America Holdings
NYSE:LH
Laboratory Corporation of America Holdings
NYSE:LH
Price:
201.32 USD
0.53%
Market Closed
Updated:
May 5, 2024
Laboratory Corporation of America Holdings
Cost of Revenue
|
Laboratory Corporation of America Holdings
Cost of Revenue Peer Comparison
Comparables:
DVA
CHE
DGX
CVS
CI
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cost of Revenue
-$8.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-9%
|
|
|
DaVita Inc
NYSE:DVA
|
Cost of Revenue
-$8.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Chemed Corp
NYSE:CHE
|
Cost of Revenue
-$1.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cost of Revenue
-$6.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cost of Revenue
-$307.3B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-11%
|
|
|
Cigna Corp
NYSE:CI
|
Cost of Revenue
-$170.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
See Also
What is Laboratory Corporation of America Holdings's Cost of Revenue?
Cost of Revenue
-8.9B
USD
-8.9B
USD
Based on the financial report for Mar 31, 2024, Laboratory Corporation of America Holdings's Cost of Revenue amounts to -8.9B USD.
What is Laboratory Corporation of America Holdings's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-9%
-9%
Over the last year, the Cost of Revenue growth was 6%. The average annual Cost of Revenue growth rates for Laboratory Corporation of America Holdings have been 2% over the past three years , -2% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
